Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 4, 1996, Pages 385-386

  Cascinu, Stefano ^a   Alessandroni, Paolo ^a   Rossi, David ^a   Del Ferro, Elena ^a   Fedeli, Anna ^a   Casadei, Virginia ^a   Catalano, Giuseppina ^a  

^a SAN SALVATORE HOSPITAL   (Italy)

Author keywords

5 FU; Biochemical modulation; Colorectal cancer

Indexed keywords

ALPHA2B INTERFERON; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG RESPONSE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; PRIORITY JOURNAL; STOMATITIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; INTERFERON ALFA-2B; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; REMISSION INDUCTION;

EID: 0030011217     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050499     Document Type: Article

References (15)

1. Peters GJ, Van Groningen CJ (1991) Clinical relevance of biochemical modulation of 5-fluorouracil. Ann Oncol 2: 469-480
2. Advanced Colorectal Cancer Meta-analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903
3. Advanced Colorectal Cancer Meta-analysis Project (1994) Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12: 960-969
4. Wadler S, Schwartz EL (1990) Antineoplastic activity of the combination of Interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50: 3473-3486
5. Corfu-A Study Group (1995) Phase III randomized study of two fluorouracil combinations with either Interferon alpha-2a or leucovorin for advanced colorectal cancer. J Clin Oncol 13: 921-928
6. Miller AB, Hoogstraten B, Staquet H, et al (1981) Reporting results of cancer treatment. Cancer 47: 207-214
7. Simon R (1989) Optimal two-stage designs for phase II clinical trials. Controlled Clin Trials 10: 1-10
8. Marsh JC, Bertino JR, Katz KH, et al (1991) The influence of drug interval on the effect of methotrexate, 5-fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol 9: 371-380
9. Kemeny NE, Ahmed T, Michaelson RA, et al (1984) Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate. J Clin Oncol 2: 311-315
10. Grem JL, McAtee N, Murphy RE, et al (1991) A pilot study of Interferon alpha-2a in combination with 5-fluorouracil plus high dose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol 9: 1811-1820
11. Cascinu S, Fedeli A, Fedeli L, et al (1992) Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose Interferon alpha-2b in advanced colorectal cancer patients. Ann Oncol 3: 489-491
12. Cascinu S, Del Ferro E, Fedeli A, et al (1993) Cytokinetic effects of Interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations. Cancer Res 53: 5429-5432
13. Labianca R, Giaccon G, Barni S, et al (1994) Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose Interferon alpha-2b and folinic acid. The GISCAD experience. Eur J Cancer 30A: 1611-1616
14. Kohne CH, Wilke H, Hecker H, et al (1995) Interferon alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). Ann Oncol 6: 461-466
15. Abad A, Garcia P, Gravalos C, et al (1995) Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. Cancer 75: 1238-1244